ICD-10-CM Code D47.1

Chronic myeloproliferative disease

Version 2021 Billable Code

Valid for Submission

D47.1 is a billable code used to specify a medical diagnosis of chronic myeloproliferative disease. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code D47.1 might also be used to specify conditions or terms like chronic eosinophilic leukemia, chronic myeloproliferative disorder , chronic neutrophilic leukemia, myelodysplastic/myeloproliferative disease, myelodysplastic/myeloproliferative neoplasm, unclassifiable, myeloproliferative disorder, etc

ICD-10:D47.1
Short Description:Chronic myeloproliferative disease
Long Description:Chronic myeloproliferative disease

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D47.1:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Chronic neutrophilic leukemia
  • Myeloproliferative disease, unspecified

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • atypical chronic myeloid leukemia BCR/ABL-negative C92.2
  • chronic myeloid leukemia BCR/ABL-positive C92.1
  • myelofibrosis NOS D75.81
  • myelophthisic anemia D61.82
  • myelophthisis D61.82
  • secondary myelofibrosis NOS D75.81

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D47.1 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Chronic eosinophilic leukemia
  • Chronic myeloproliferative disorder
  • Chronic neutrophilic leukemia
  • Myelodysplastic/myeloproliferative disease
  • Myelodysplastic/myeloproliferative neoplasm, unclassifiable
  • Myeloproliferative disorder
  • Thrombophilia due to myeloproliferative disorder
  • Undifferentiated myeloproliferative disease

Diagnostic Related Groups

The ICD-10 code D47.1 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC
  • 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC
  • 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC

Convert D47.1 to ICD-9

  • 238.76 - Myelofi w myelo metaplas (Approximate Flag)
  • 238.79 - Lymph/hematpoitc tis NEC (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
      • Oth neoplm of uncrt behav of lymphoid, hematpoetc & rel tiss (D47)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Bone Marrow Diseases

Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.

With bone marrow disease, there are problems with the stem cells or how they develop:

  • In leukemia, a cancer of the blood, the bone marrow makes abnormal white blood cells
  • In aplastic anemia, the bone marrow doesn't make red blood cells
  • In myeloproliferative disorders, the bone marrow makes too many white blood cells
  • Other diseases, such as lymphoma, can spread into the bone marrow and affect the production of blood cells

Causes of bone marrow diseases include genetics and environmental factors. Tests for bone marrow diseases include blood and bone marrow tests. Treatments depend on the disorder and how severe it is. They might involve medicines, blood transfusions or a bone marrow transplant.

  • Bone marrow aspiration (Medical Encyclopedia)
  • Bone marrow culture (Medical Encyclopedia)
  • Bone marrow transplant (Medical Encyclopedia)
  • Bone marrow transplant - discharge (Medical Encyclopedia)
  • Myelofibrosis (Medical Encyclopedia)
  • Polycythemia vera (Medical Encyclopedia)

[Learn More]